DS
OPTR

David Shaw’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

David Shaw’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-349,857
Closed -$4.41M – 4921
2013
Q3 		$4.41M Buy
349,857
+164,926
+89% +$2.19M 0.01% 1716
2013
Q2 		$2.68M Buy
+184,931
New +$2.69M 0.01% 1854

David Shaw's OPTR Position: Q4 2013 in Review

David Shaw sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 349,857 shares — an estimated $4.41M sold.

David Shaw first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $4.41M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • David Shaw reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • David Shaw sold 349,857 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $4.41M.
  • David Shaw first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • David Shaw's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $4.41M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on D.E. Shaw & Co's 13F filing for Q4 2013, filed 14 Feb 2014.